Lab 21 First UK Outlet for New 20 Respiratory Virus Panel Diagnostic Assay
Lab 21 announces the launch of a revolutionary new assay able to detect any virus from a panel of 20 distinct respiratory viruses using multiplex detection technology. The respiratory virus panel (RVP) assay was developed by Tm Biosciences who recently received CE Mark approval for its use in clinical diagnostic procedures.
The assay is currently in the final stages of validation at Lab 21’s advanced testing laboratory based at its Cambridge facility and will be available to all customers including private clinics and NHS hospitals beginning in mid January 2006.
The RVP is a proprietary test that simultaneously detects up to 20 distinct viral sequences and subtypes that represent more than 95 percent of all clinically relevant respiratory viruses in adults and children. Viruses detected using the assay include respiratory syncytial virus A and B, influenza A and B and viruses important in patient management and pandemic surveillance, such as SARS and influenza A H5 (the subtype associated with avian influenza). Lab 21 has a separate identification test which can confirm positive H5N1 samples. Results for all of these viruses can be provided within 24 hours of receipt of sample in the Lab 21 laboratory.
Jerry Walker CEO of Lab 21 stated, “We are delighted to be able to offer this important service and have been working with our existing customers to assess the performance of the test in our molecular diagnostics laboratory in Cambridge. We will be marketing the service from January 2007 onwards in time for peak ‘flu season.”
Berwyn Clarke, CSO of Lab 21 added, “ Our ability to offer another gold-standard service is testament to our efforts to develop Lab 21 into a leading UK clinical reference laboratory and enhances our already strong position in virology yet further. The real value of this test lies in its ability to identify those respiratory viral infections for which therapeutic intervention is currently available while, at the same time, it provides a rapid and sensitive tool for epidemiologic studies.”
Marc Southern (Lab 21 Ltd)
Email : firstname.lastname@example.org
Tel : +44 (0) 1489 898 600
Marc Southern | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
Nano-hologram paves way for integration of 3-D holography into everyday electronics
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...